Please login to the form below
genomics
This page shows the latest genomics news and features for those working in and with pharma, biotech and healthcare.
UK to provide genomic sequencing globally to identify COVID-19 variants
Public Health England has identified the first group of countries to receive genomic sequencing support through NVAP. ... PHE has already sequenced genomic samples from countries that have requested support – including Ukraine, Kyrgyzstan, Tajikistan,
Latest news
-
Fool’s gold or pot of gold? The challenges of demonstrating the value of tumour agnostic therapies
This move towards TA R&D is a natural continuation of the PD-1/PD-L1 success story that has driven the clinical community towards a more genomic approach to treating
-
NICE sets out plans for ‘ambitious’ five-year strategy
The healthcare of the future will look radically different from today – new therapies will combine pills with technologies, genomic medicine will make early disease detection a reality and AI and machine
-
Lilly’s RET inhibitor Retevmo shows early promise in new cancer types
the underlying genomic driver of their cancer," said Vivek Subbiah, associate professor in the Investigational Cancer Therapeutics Department and centre clinical medical director of the Clinical Center for Targeted Therapy at ... These results
-
UK plans to launch new national health agency focused on tackling pandemics
This includes harnessing the data analytics and genomic surveillance capabilities of these organisations, along with scale testing and contract tracing capability.
-
GSK, Vir halt enrolment of phase 3 COVID-19 antibody study
The collaboration combines Vir Biotech’s monoclonal antibody platform technology with GSK’s expertise in functional genomics and capabilities in CRISPR screening to identify anti-coronavirus compounds.
More from news
Approximately 23 fully matching, plus 178 partially matching documents found.
Latest Intelligence
-
How early-stage clinical research is facilitating the new wave of personalised medicines
This is being progressed through the NHS Genomic Medicine Service which builds on the work of Genomics England to routinely offer NHS patients access to molecular and genomic testing. ... This investment in genomic technology and research, plus the
-
The promise of precision medicine
In Qatar, research into genomics and precision medicine is being used to tackle diseases such as obesity, diabetes and cardiovascular disease. ... Meanwhile, clinicians in the United States have been increasingly using genomic insights to inform their
-
AI and accelerated computing ring in new era for healthcare
of chemical structures, in-silico methods for screening, protein-ligand interactions, genomic analysis, and assimilating data from structured and unstructured sources. ... Genomic analyses can provide invaluable insights for researchers, helping them
-
Rare genetic diseases – what’s in store for 2021?
Understanding of genetics and DNA has come a long way, with labs around the world now using an individual’s genomic information to understand that individual’s risk of specific diseases ... We may be able to firmly establish genomic profiling to
-
Digital healthcare may revolutionise management of chronic diseases, but who is going to pay for it?
sciences in big data, genomics and artificial intelligence’.
More from intelligence
Approximately 8 fully matching, plus 50 partially matching documents found.
Latest appointments
-
Mark Caulfield departs from Genomics England to take on CEO role at Barts Life Sciences
Caulfield served as chief scientist at Genomics England, working on the 100, 000 Genomes Project. ... He was awarded a knighthood in 2019 following the project’s ‘unprecedented success’, Genomics England said in a statement.
-
BMS appoints new commercial leader, Davies joins Eisai and more
Congenica poaches AZ’s business performance director. Currently director of business performance at AstraZeneca, Wendy Britten (pictured) has decided to join Cambridge, UK-based Cogenica, a clinical genomics interpretation software provider.
-
Editas Medicine names James Mullen as chairman
Jim’s extensive experience in driving excellence across R&D, commercialisation, manufacturing, business development and capital formation will be invaluable as we continue to build a genomic medicine leader and develop
-
Global Gene Corp appoints new chief data and technology officer
Cambridge, UK-based genomics platform group Global Gene Corp (GGC), has appointed Dr Yaron Turpaz as its new chief data and technology officer, and managing director of the group’s Singapore ... I am looking forward to our journey together to create
-
Decibel Therapeutics expands leadership team
genomic technologies.
More from appointments
Approximately 3 fully matching, plus 20 partially matching documents found.
Latest from PMHub
-
Learning about Rare Genetic Disorders on Undiagnosed Children’s Day
As part of our commitment to the field of advanced therapies, emotive recently met with Genomics England, the masterminds behind the 100, 000 Genomes Project, to find out more. Stay posted
-
What do NHS changes and the Life Sciences Vision mean for medicines?
Also threaded through the strategy is the drive to increase research in the NHS and the harnessing of genomic and health data for this purpose.
-
Realizing the Potential of Genomics-Driven Precision Medicine
Jennifer Helfer, Senior Director, Patient Advocacy &Engagement at Encoded Therapeutics Inc., discusses genomics-driven precision medicine, gene therapy misconceptions and fears, involving patients and caregivers in designing gene therapy trials, how
-
Building the hospital of the future
latest technologies around artificial intelligence, deep learning, data analytics, genomics, home‑based healthcare, robotics, and 3D printing of tissues and implants.”.
-
Advancing Precision Medicine in Oncology
He also dives into the promises and pitfalls of genomic testing and precision medicine in oncology, and gives his take on how to build authentic relationships with oncology KOLs during and
What do NHS changes and the Life Sciences Vision mean for medicines?
More from PMHub
Approximately 11 fully matching, plus 20 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Medical Writers > Scientific Directors – Medical Communicatio...
-
Highly Competitive Salary, Bonus &Benefits
- Account Supervisor – Leading Healthcare Advertising Agency – New...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account Exec > CSD – Medical Communications – UK, Lond...
-
Highly Competitive Salary, Bonus &Benefits
- Client Services Director, MRNA/ Covid 19, Medical Communications...
-
Highly competitive salary
- Senior Medical Writer – Creative Healthcare Advertising – New Yo...
-
Highly Competitive Salary, Bonus &Benefits
- Vaccines writer – career opportunity to move into medcomms from ...
-
Highly competitive salary
-
B2B media account director
-
Competitive salary
- Scientific Director, MRNA/ Covid 19, Medical Communications, UK
-
Six figure salary
- Principal Medical Writer, MRNA/ Covid 19, Medical Communications...
-
Highly competitive salary
- First trial of a vaccine against Alzheimer’s launches
- Gilead’s Trodelvy approved for triple-negative breast cancer in Europe
- Roche to present new data for its drug Polivy at the American Society of Hematology’s annual meeting
- US government to pay $5.3bn for Pfizer‘s Paxlovid
- bluebird bio’s beti-cel accepted for priority review by FDA
- Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention
- Booster plans expanded to combat Omicron
- US regulators set to approve oral antiviral against COVID-19
- What does the future hold for Light-chain Amyloidosis?
- As HCPs Increasingly Expect Personalized Engagement, Pharmas Turn to Modular Intelligent Content. How Does This Work?
- COVID-19 vaccines against Omicron may be fast-tracked
- BMS’ new JAK inhibitor enters regulatory pathways
- Results for Merck’s oral cholesterol inhibitor show it to be ‘highly effective’
- Biogen hands out $120m upfront for Remedy stroke drug
- EMA to evaluate Roche arthritis drug RoActemra for severe COVID-19
- Pfizer fined $60m for bribing doctors to win business
- Pfizer's 2021 revenue predictions soar to $82bn
- Synairgen’s SNG001 advances into phase 3 COVID-19 trial
PMHub
Cegedim Health Data
Cegedim Health Data provides Real World Data and Evidence services to enable advancements in patient outcomes. With a data history...
Latest intelligence
- What does the future hold for Light-chain Amyloidosis?
- Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
- Webinar:
- Securing a future for telehealth with immersive market research insights...
- Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
- How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
